Fluence Training Provides Top-Flight Therapists For Tryp Therapeutics’ Phase 2a For Eating Disorder Sep 9, 2021
Part #1 & 2: COO Damon Michaels On Mydecine’s Collaboration With Johns Hopkins University Aug 27, 2021
Part 1 and 2: PharmaDrug CEO Daniel Cohen On Johns Hopkins University Partnership To Evaluate DMT Aug 27, 2021
